Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid
- 1 February 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (2), 556-558
- https://doi.org/10.1128/aac.39.2.556
Abstract
The aim of this study was to examine the effects of ganciclovir and nalidixic acid either alone or in combination on duck hepatitis B virus DNA replication in vivo with particular reference to production of viral supercoiled DNA and RNA. The most effective antiviral response was observed in the livers of ducks treated by the combination therapy for 28 days, which resulted in a substantial decrease in the amounts of viral supercoiled DNA, relaxed circular and single-stranded DNA, and also viral RNA. This combination treatment was not hepatotoxic over the study period.Keywords
This publication has 18 references indexed in Scilit:
- Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapyLiver International, 1994
- In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusAntimicrobial Agents and Chemotherapy, 1994
- Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compoundsJournal of Medical Virology, 1990
- INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDSThe Lancet, 1989
- In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirusAntimicrobial Agents and Chemotherapy, 1989
- DNA topoisomerases as potential targets of antiviral actionPharmacology & Therapeutics, 1989
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infectionHepatology, 1987
- Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver DiseaseSeminars in Liver Disease, 1986
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediateCell, 1982